Department of Pharmacology and.
Scientific Service Group Nuclear Magnetic Resonance Imaging, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
JCI Insight. 2016 May 19;1(7):e81175. doi: 10.1172/jci.insight.81175.
Obesity is an increasing health problem worldwide, and nonsurgical strategies to treat obesity have remained rather inefficient. We here show that acute loss of TGF-β-activated kinase 1 (TAK1) in adipocytes results in an increased rate of apoptotic adipocyte death and increased numbers of M2 macrophages in white adipose tissue. Mice with adipocyte-specific TAK1 deficiency have reduced adipocyte numbers and are resistant to obesity induced by a high-fat diet or leptin deficiency. In addition, adipocyte-specific TAK1-deficient mice under a high-fat diet showed increased energy expenditure, which was accompanied by enhanced expression of the uncoupling protein UCP1. Interestingly, acute induction of adipocyte-specific TAK1 deficiency in mice already under a high-fat diet was able to stop further weight gain and improved glucose tolerance. Thus, loss of TAK1 in adipocytes reduces the total number of adipocytes, increases browning of white adipose tissue, and may be an attractive strategy to treat obesity, obesity-dependent diabetes, and other associated complications.
肥胖是一个日益严重的全球健康问题,治疗肥胖的非手术策略仍然效率不高。我们在这里表明,脂肪细胞中 TGF-β 激活激酶 1(TAK1)的急性缺失会导致脂肪细胞凋亡死亡的速度增加,以及白色脂肪组织中 M2 巨噬细胞数量的增加。脂肪细胞特异性 TAK1 缺乏的小鼠脂肪细胞数量减少,并且对高脂肪饮食或瘦素缺乏引起的肥胖具有抗性。此外,高脂肪饮食下脂肪细胞特异性 TAK1 缺乏的小鼠表现出能量消耗增加,这伴随着解偶联蛋白 UCP1 的表达增强。有趣的是,在已经处于高脂肪饮食的小鼠中急性诱导脂肪细胞特异性 TAK1 缺失能够阻止体重进一步增加并改善葡萄糖耐量。因此,脂肪细胞中 TAK1 的缺失会减少脂肪细胞的总数,增加白色脂肪组织的褐色化,并且可能是治疗肥胖症、肥胖相关糖尿病和其他相关并发症的一种有吸引力的策略。